| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Bellerophon Therapeutics, Inc. | VP Reg. Affairs & Quality | Stock Options (Right to Buy) | 50,000 | $155,000 | $3.10 | 07 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000110465923069907-kim-bobae-2023-06-07 | Bellerophon Therapeutics, Inc. | 07 Jun 2023 | 1 | $0 | 4 | VP Reg. Affairs & Quality | 09 Jun 2023, 16:10 |
| /report/000110465923063263-kim-bobae-2023-05-18 | Bellerophon Therapeutics, Inc. | 18 May 2023 | 5 | -$84,930 | 4 | VP Reg. Affairs & Quality | 22 May 2023, 18:51 |
| /report/000141588923005819-kim-bobae-2023-03-30 | Bellerophon Therapeutics, Inc. | 30 Mar 2023 | 0 | $0 | 3 | VP Reg. Affairs & Quality | 03 Apr 2023, 17:46 |